Hassel, J. C. (2017). Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions. Cancer treatment reviews, 57, . https://doi.org/10.1016/j.ctrv.2017.05.003
Chicago-Zitierstil (17. Ausg.)Hassel, Jessica C. "Combined Immune Checkpoint Blockade (anti-PD-1/anti-CTLA-4): Evaluation and Management of Adverse Drug Reactions." Cancer Treatment Reviews 57 (2017). https://doi.org/10.1016/j.ctrv.2017.05.003.
MLA-Zitierstil (9. Ausg.)Hassel, Jessica C. "Combined Immune Checkpoint Blockade (anti-PD-1/anti-CTLA-4): Evaluation and Management of Adverse Drug Reactions." Cancer Treatment Reviews, vol. 57, 2017, https://doi.org/10.1016/j.ctrv.2017.05.003.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.